英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
spj查看　spj　在百度字典中的解释百度英翻中〔查看〕
spj查看　spj　在Google字典中的解释Google英翻中〔查看〕
spj查看　spj　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ENTYVIO® (vedolizumab) for Crohns Disease or Ulcerative Colitis
    Please see accompanying full Prescribing Information, including the Medication Guide, for ENTYVIO and talk with your healthcare provider ENTYVIO is available for: intravenous (IV) infusion: 300 mg vedolizumab subcutaneous (SC) injection: 108 mg vedolizumab You are encouraged to report negative side effects of prescription drugs to the FDA
  • ENTYVIO (vedolizumab) for injection, for intravenous use ENTYVIO . . .
    FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE ENTYVIO is indicated in adults for the treatment of: • moderately to severely active ulcerative colitis (UC) • moderately to severely active Crohn’s disease (CD) 2 DOSAGE AND ADMINISTRATION 2 1 Important Administration Information
  • ENTYVIO® (vedolizumab) - Official HCP Website
    ENTYVIO (vedolizumab) prescribing information Takeda Pharmaceuticals Sands BE, Peyrin-Biroulet L, Loftus EV Jr, et al Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis N Engl J Med 2019;381(13):1215-1226
  • Entyvio (Infusion Pen): Uses, Side Effects, Dosage - Drugs. com
    Entyvio PI HCPs and patients often use the Entyvio PI for more detailed information about this medicine The Entyvio PI (prescribing information) contains more comprehensive information on Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies, Drug Interaction, and more
  • Entyvio (Vedolizumab for Injection, for Intravenous Use . . . - RxList
    Sections or subsections omitted from the full prescribing information are not listed Patients may self-inject or caregivers may inject subcutaneous ENTYVIO using either the ENTYVIO prefilled syringe or ENTYVIO PEN after training in subcutaneous injection technique Provide proper training to patients and or caregivers on the subcutaneous
  • These Clinical Guidelines have been created by CarepathRx solely for . . .
    Refer to manufacturer’s full Prescribing Information for most up to date information A Indications: Adult Ulcerative Colitis and Adult Crohn’s disease B Dose (for both Ulcerative Colitis and Crohn’s disease): 1 Induction dosing: 300 mg IV at weeks 0, 2, 6 2 Maintenance dosing: 300 mg IV every 8 weeks thereafter 3
  • ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European Medicines Agency
    Entyvio 300 mg powder for concentrate for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 300 mg of vedolizumab After reconstitution, each mL contains 60 mg of vedolizumab Vedolizumab is a humanised IgG 1 monoclonal antibody produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology
  • Dosing and - ENTYVIO® (vedolizumab) HCP Website
    ENTYVIO is indicated in adults for the treatment of moderately to severely active CD DOSAGE FORMS STRENGTHS ENTYVIO Intravenous (IV) Infusion: 300 mg vedolizumab; ENTYVIO Subcutaneous (SC) Injection: 108 mg vedolizumab; Please click for Full Prescribing Information
  • This label may not be the latest approved by FDA. For current labeling . . .
    o Discontinue ENTYVIO in patients who do not show evidence of therapeutic benefit by Week 14 (2 2, 2 3) Preparation and Administration Instructions for Intravenous Infusion (2 4): o See full prescribing information for complete information on reconstitution, dilution, administration, and storage DOSAGE FORMS AND STRENGTHS -----
  • PRESCRIBING INFORMATION 1. NAME OF THE MEDICINAL PRODUCT 2. QUALITATIVE . . .
    PRESCRIBING INFORMATION 1 NAME OF THE MEDICINAL PRODUCT Entyvio powder for concentrate for solution for infusion 300mg vial (vedolizumab) Entyvio solution for injection in pre-filled pen autoinjector 108mg 0 68ml (vedolizumab) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Vedolizumab is a humanised IgG 1 monoclonal antibody that binds to the





中文字典-英文字典  2005-2009